Journal
Journal of Lipid Research
Publication Date
9-1-2024
Volume
65
Issue
9
First Page
100611
Document Type
Open Access Publication
DOI
10.1016/j.jlr.2024.100611
Rights and Permissions
Moon SH, Liu X, Jenkins CM, Dilthey BG, Patti GJ, Gross RW. Etomoxir-carnitine, a novel pharmaco-metabolite of etomoxir, inhibits phospholipases A2 and mitochondrial respiration. J Lipid Res. 2024 Sep;65(9):100611. doi: 10.1016/j.jlr.2024.100611. © 2024 THE AUTHORS. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)
Recommended Citation
Moon, Sung Ho; Liu, Xinping; Jenkins, Christopher M; Dilthey, Beverly Gibson; Patti, Gary J; and Gross, Richard W, "Etomoxir-carnitine, a novel pharmaco-metabolite of etomoxir, inhibits phospholipases A2 and mitochondrial respiration." Journal of Lipid Research. 65, 9. 100611 (2024).
https://digitalcommons.wustl.edu/oa_4/5186
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
